CoronaVac
CoronaVac is an inactivated vaccine for COVID-19 developed by Sinovac, a China-based biopharmaceutical company.
Pronunciation
CoronaVac is pronounced as /kəˈroʊnəvæk/.
Etymology
The name "CoronaVac" is derived from the virus it protects against, the coronavirus, and "vac" from vaccine.
Description
CoronaVac is an inactivated vaccine, which means it uses a non-infectious version of the coronavirus to stimulate an immune response in the body. The vaccine is administered in two doses, 14 days apart.
Efficacy
The efficacy of CoronaVac varies depending on the population in which it is administered. In clinical trials in Brazil, it was found to be 50.7% effective at preventing symptomatic infections, while in Turkey, it was found to be 83.5% effective.
Side Effects
Common side effects of CoronaVac include pain at the injection site, fatigue, headache, muscle pain, and joint pain. Severe side effects are rare.
Related Terms
See Also
- COVID-19 vaccine
- Pfizer-BioNTech COVID-19 vaccine
- Moderna COVID-19 vaccine
- Oxford–AstraZeneca COVID-19 vaccine
External links
- Medical encyclopedia article on CoronaVac
- Wikipedia's article - CoronaVac
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski